Insmed to Participate at November Investor Conferences
November 14 2016 - 8:00AM
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company focused on the unmet needs of patients with rare diseases,
today reported that the company will participate at the following
investor conferences taking place in New York City:
- Will Lewis, president and chief executive officer, will
participate in an analyst-led fireside chat on Wednesday, November
16 at 10:15 AM ET at the Stifel Healthcare Conference.
- Mr. Lewis will also participate in an analyst-led fireside chat
on Tuesday, November 29 at 7:30 AM ET at the Piper Jaffray
Healthcare Conference.
The presentations will be webcast live and can be
accessed by visiting the investor relations section of the
company’s website at www.insmed.com. The webcast will be archived
for a period of 90 days following the live webcast.
About Insmed
Insmed Incorporated is a global biopharmaceutical
company focused on the unmet needs of patients with rare diseases.
The company is advancing a global phase 3 clinical study of
ARIKAYCE (liposomal amikacin for inhalation) in nontuberculous
mycobacteria (NTM) lung disease, a rare and often chronic infection
that is capable of causing irreversible lung damage and can be
fatal. There are currently no products indicated for the treatment
of NTM lung disease in the United States or European Union (EU).
Insmed’s earlier-stage clinical pipeline includes INS1007, a novel
oral inhibitor of dipeptidyl peptidase I with therapeutic potential
in non-cystic fibrosis bronchiectasis, and INS1009, an inhaled
prodrug formulation of treprostinil that may offer a differentiated
product profile for rare pulmonary disorders. For more information,
visit www.insmed.com.
“Insmed” and “ARIKAYCE” are the company's
trademarks. All other trademarks, trade names or service marks
appearing in this press release are the property of their
respective owners.
Insmed Incorporated:
Susan Mesco
Head of Investor Relations
908-947-4326
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Apr 2023 to Apr 2024